HempPetVet
A structured clinical course for registered veterinarians — covering receptor anatomy, endogenous ligands, phytocannabinoid pharmacology, clinical applications, and Australian regulatory compliance.
Five evidence-informed modules with interactive checkpoints
CB1 and CB2 receptor distribution across canine and feline CNS and peripheral tissues. Comparative localisation and neuropharmacological sensitivity.
SlidesTest your understanding of CB1/CB2 receptor distribution and functional roles in companion animals.
Quiz — 2 questionsExplore AEA & 2-AG biosynthesis, receptor binding, and enzymatic clearance by FAAH/MAGL with an interactive diagram.
Interactive ModuleAnandamide (AEA) and 2-arachidonoylglycerol (2-AG): biosynthesis, signalling, and degradation by FAAH and MAGL.
SlidesTest your understanding of AEA vs 2-AG efficacy, receptor profiles, and enzymatic degradation pathways.
Quiz — 2 questionsExplore how THC, CBD, CBG & terpenes interact with CB1, CB2, TRPV1, GPR55 & 5-HT1A receptors.
Interactive ModuleΔ9-THC, CBD, CBG and the terpene entourage effect. Receptor binding profiles, pharmacokinetics, and species-relevant dose considerations.
SlidesTest your understanding of CBD vs THC mechanisms and terpene entourage pharmacology.
Quiz — 2 questionsExplore CBD hepatic metabolism, clinical applications, THC toxicosis pathway & the >10mg/mL safety threshold.
Interactive ModuleEvidence-based CBD in canine epilepsy and osteoarthritis. Peer-reviewed efficacy, pharmacokinetics, and regulatory guidelines.
SlidesCannabis toxicosis in dogs — clinical manifestations, the >10 mg/mL compounded-preparation safety threshold, and emergency management protocols.
SlidesTest your understanding of CBD hepatic interactions, THC toxicosis management, and CYP450 drug-drug interactions.
Quiz — 3 questionsExplore SUSMP scheduling, compounding rules, 7-year record-keeping & controlled drug register requirements.
Interactive ModuleSUSMP scheduling, compounded preparation limits, 7-year record-keeping obligations, and responsible veterinary access pathways.
SlidesTest your understanding of SUSMP scheduling, compounding regulations, and controlled substance record-keeping.
Quiz — 2 questionsExplore CB1 & CB2 distribution patterns across canine and feline anatomy with an interactive mapping tool.
Interactive ModuleThis course is intended for veterinary continuing education purposes. It does not constitute veterinary advice or a recommendation to prescribe any specific product. Cannabinoid products remain subject to Australian scheduling and regulatory controls. Practitioners should exercise clinical judgement and comply with all applicable state and federal requirements. No therapeutic claims are made for unapproved products.